Sheila Sanchez
Family Medicine · North Miami Beach, FLNPI 1164605523
Payments from drug & device makers
Across 4,240 payments — averaging $1348.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$3M
- Seqirus USA Inc$1.4M
- Bavarian Nordic A/s$912K
- Pfizer$325K
- Hexal AG$53K
- GSK$7K
- plus $437 from 11 others
What the payments were for
- Travel & lodging$52036%
- Food & beverage$92364%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 3,185 | $3,032,530 |
| Seqirus USA Inc | 922 | $1,386,614 |
| Bavarian Nordic A/s | 65 | $911,919 |
| Pfizer | 44 | $324,798 |
| Hexal AG | 6 | $53,162 |
| GSK | 5 | $6,770 |
| Boston Scientific | 1 | $156 |
| Sanofi Pasteur Inc. | 2 | $48 |
| Medtronic | 1 | $42 |
| Abbott | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Johnson & Johnson | 1 | $27 |
| Novo Nordisk | 1 | $23 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Merck | 1 | $20 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$156
How this compares
$5,716,230 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $72,153 |
| EliquisApixaban | 51 | $69,156 |
| FarxigaDapagliflozin Propanediol | 70 | $67,778 |
| JanuviaSitagliptin Phosphate | 30 | $37,132 |
| MounjaroTirzepatide | 22 | $31,726 |
| JardianceEmpagliflozin | 15 | $23,642 |
| TradjentaLinagliptin | 20 | $16,890 |
| Repatha SyringeEvolocumab | 15 | $15,066 |
| LinzessLinaclotide | 16 | $12,544 |
| RestasisCyclosporine | 13 | $11,925 |
| VascepaIcosapent Ethyl | 15 | $7,990 |
| Diclofenac Sodium | 285 | $5,718 |
| JentaduetoLinagliptin/Metformin Hcl | 11 | $5,680 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $4,129 |
| Novolog FlexpenInsulin Aspart | 12 | $2,207 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $23 | $72,15357 claims |
| PfizerEliquis | $324,798 | $69,15651 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto | $28 | $46,21246 claims |
| MerckJanuvia | $20 | $37,13230 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in North Miami Beach
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.